Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Paroxetine withdrawal syndrome].

L Belloeuf¹, C Le Jeunne, F C Hugues

¹Service de Médecine Interne et de Thérapeutique, Hôpital Laennec, Paris.

Annales De Medecine Interne

|June 16, 2000

Summary

Serotonin re-uptake inhibitor withdrawal syndrome, particularly with paroxetine, presents unique clinical features. Gradual dose reduction and patient education are key to preventing and managing this common antidepressant discontinuation syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Contribution and limits of "OSCE", "long-case" and "global end-of-placement marking" as end-of-rotation assessment methods. Experience from two internal medicine wards].

La Revue de medecine interne·2022

Same author

[Association between psychiatric comorbidities and hospital length of stay in post-emergency internal medicine patients].

La Revue de medecine interne·2020

Same author

[Reliability and validity of a workbook for assessment of professional competencies of internal medicine residents].

La Revue de medecine interne·2019

Same author

Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

[Lymphocytic meningitis in a 70-year-old woman].

La Revue de medecine interne·2016

Same author

Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases.

Lupus·2015

Area of Science:

Neuroscience
Pharmacology

Background:

Selective serotonin reuptuptake inhibitors (SSRIs) are widely prescribed antidepressants.
Physician awareness of SSRI withdrawal syndrome, especially with paroxetine, remains limited.
Variable incidence and clinical presentations complicate diagnosis and management.

Observation:

SSRI withdrawal symptoms typically emerge within 24-48 hours of discontinuation.
Peak symptom intensity occurs around day 5, with resolution usually within 2-3 weeks.
Short half-life SSRIs like paroxetine and fluvoxamine are associated with higher withdrawal incidence.

Findings:

Common symptoms include dizziness, vertigo, headache, nausea, flu-like symptoms, anxiety, confusion, irritability, insomnia, and vivid dreams.
Withdrawal severity correlates with daily dosage and duration of SSRI treatment.
Risk factors include poor compliance, prior withdrawal history, polypharmacy, and alcohol use.

Implications:

Preventive strategies involve gradual dose tapering and comprehensive patient education.
Reintroducing the SSRI followed by a slow taper is recommended for managing existing withdrawal symptoms.
Enhanced physician education on SSRI withdrawal is crucial for improved patient care and treatment adherence.

Related Experiment Videos